Westway Medics Limited 10274359 false 2022-08-01 2023-07-31 2023-07-31 The principal activity of the company is medical services Digita Accounts Production Advanced 6.30.9574.0 true 10274359 2022-08-01 2023-07-31 10274359 2023-07-31 10274359 bus:OrdinaryShareClass1 2023-07-31 10274359 core:CurrentFinancialInstruments 2023-07-31 10274359 core:CurrentFinancialInstruments core:WithinOneYear 2023-07-31 10274359 core:OtherPropertyPlantEquipment 2023-07-31 10274359 bus:SmallEntities 2022-08-01 2023-07-31 10274359 bus:AuditExemptWithAccountantsReport 2022-08-01 2023-07-31 10274359 bus:AbridgedAccounts 2022-08-01 2023-07-31 10274359 bus:SmallCompaniesRegimeForAccounts 2022-08-01 2023-07-31 10274359 bus:RegisteredOffice 2022-08-01 2023-07-31 10274359 bus:CompanySecretaryDirector1 2022-08-01 2023-07-31 10274359 bus:OrdinaryShareClass1 2022-08-01 2023-07-31 10274359 bus:PrivateLimitedCompanyLtd 2022-08-01 2023-07-31 10274359 core:OtherPropertyPlantEquipment 2022-08-01 2023-07-31 10274359 core:PlantMachinery 2022-08-01 2023-07-31 10274359 countries:EnglandWales 2022-08-01 2023-07-31 10274359 2022-07-31 10274359 core:OtherPropertyPlantEquipment 2022-07-31 10274359 2021-08-01 2022-07-31 10274359 2022-07-31 10274359 bus:OrdinaryShareClass1 2022-07-31 10274359 core:CurrentFinancialInstruments 2022-07-31 10274359 core:CurrentFinancialInstruments core:WithinOneYear 2022-07-31 10274359 core:OtherPropertyPlantEquipment 2022-07-31 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 10274359

Westway Medics Limited

Unaudited Filleted Abridged Financial Statements

for the Year Ended 31 July 2023

 

Westway Medics Limited

Contents

Company Information

1

Abridged Balance Sheet

2 to 3

Notes to the Unaudited Abridged Financial Statements

4 to 6

 

Westway Medics Limited

Company Information

Director

Dr Alan Jumaily

Company secretary

Dr Alan Jumaily

Registered office

Charles Rippin & Turner
Middlesex House
130 College Road
Harrow
Middlesex
HA1 1BQ

Accountants

Charles Rippin & Turner
Middlesex House
130 College Road
Harrow
Middlesex
HA1 1BQ

 

Westway Medics Limited

(Registration number: 10274359)
Abridged Balance Sheet as at 31 July 2023

Note

2023
£

2022
£

Fixed assets

 

Tangible assets

4

29,457

28,639

Current assets

 

Debtors

80,000

-

Cash at bank and in hand

 

9,060

37,212

 

89,060

37,212

Creditors: Amounts falling due within one year

(79,021)

(26,782)

Net current assets

 

10,039

10,430

Total assets less current liabilities

 

39,496

39,069

Accruals and deferred income

 

(2,705)

(2,800)

Net assets

 

36,791

36,269

Capital and reserves

 

Called up share capital

5

1

1

Retained earnings

36,790

36,268

Shareholders' funds

 

36,791

36,269

For the financial year ending 31 July 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

All of the company’s members have consented to the preparation of an Abridged Balance Sheet in accordance with Section 444(2A) of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 19 January 2024
 

 

Westway Medics Limited

(Registration number: 10274359)
Abridged Balance Sheet as at 31 July 2023

.........................................
Dr Alan Jumaily
Company secretary and director

 

Westway Medics Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 July 2023

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Charles Rippin & Turner
Middlesex House
130 College Road
Harrow
Middlesex
HA1 1BQ

These financial statements were authorised for issue by the director on 19 January 2024.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These abridged financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These abridged financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Plant and machinery

20% Reducing balance

 

Westway Medics Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 July 2023

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Borrowings

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortised cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the profit and loss account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings are classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

3

Staff numbers

The average number of persons employed by the company (including the director) during the year, was 0 (2022 - 1).

 

Westway Medics Limited

Notes to the Unaudited Abridged Financial Statements for the Year Ended 31 July 2023

4

Tangible assets

Other tangible assets
£

Total
£

Cost or valuation

At 1 August 2022

31,470

31,470

Additions

3,025

3,025

At 31 July 2023

34,495

34,495

Depreciation

At 1 August 2022

2,831

2,831

Charge for the year

2,207

2,207

At 31 July 2023

5,038

5,038

Carrying amount

At 31 July 2023

29,457

29,457

At 31 July 2022

28,639

28,639

5

Share capital

Allotted, called up and fully paid shares

 

2023

2022

 

No.

£

No.

£

Ordinary share capital of £1 each

1

1

1

1